Human Medicines European Public Assessment Report (EPAR): Prasugrel Mylan, Prasugrel, Myocardial Infarction,Acute Coronary Syndrome,Angina, Unstable, Date of Authorisation: 15/05/2018, Revision: 3, Status: Authorised

Case Medical Research
doi 10.31525/cmr-fe2415
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): DuoPlavin, Clopidogrel / Acetylsalicylic Acid, Acute Coronary Syndrome,Myocardial Infarction, Date of Authorisation: 14/03/2010, Revision: 18, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Tadalafil Mylan, Tadalafil, Erectile Dysfunction, Date of Authorisation: 21/11/2014, Revision: 8, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Clopidogrel Ratiopharm GmbH, Clopidogrel, Peripheral Vascular Diseases,Acute Coronary Syndrome,Myocardial Infarction,Stroke, Date of Authorisation: 28/07/2009, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Rebetol, Ribavirin, Hepatitis C, Chronic, Date of Authorisation: 06/05/1999, Revision: 32, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Brilique, Ticagrelor, Peripheral Vascular Diseases,Acute Coronary Syndrome, Date of Authorisation: 03/12/2010, Revision: 12, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Revinty Ellipta, Fluticasone Furoate / Vilanterol, Asthma, Date of Authorisation: 02/05/2014, Revision: 16, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy